0 366

Cited 4 times in

A multicenter prospective observational study on the safety and efficacy of tacrolimus in patients with myasthenia gravis

DC Field Value Language
dc.contributor.author신하영-
dc.date.accessioned2018-07-20T07:49:53Z-
dc.date.available2018-07-20T07:49:53Z-
dc.date.issued2017-
dc.identifier.issn0022-510X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/160564-
dc.description.abstractINTRODUCTION: Several clinical studies using tacrolimus revealed reasonable therapeutic mechanisms and efficacy in patients with myasthenia gravis (MG). However, long-period studies in a large number of patients with MG are limited; therefore, the aim of this study was to investigate the therapeutic efficacies and safety of tacrolimus in patients with MG during a 12-month follow-up period. METHODS: Tacrolimus was administered to 150 patients with MG who were recruited based on the inclusion criteria. Fifteen medical centers in Korea participated in this study. The efficacy of tacrolimus was assessed using MG composite scales (MGCS) and the prednisolone-sparing effect. And the adverse drug reactions (ADRs) of tacrolimus were monitored in each patient from the beginning of tacrolimus treatment to the end of the follow-up period. RESULTS: After starting tacrolimus, the 32 patients were affected by ADRs, and consequentially 134 patients of the enrolled patients were followed up for 12months. They showed that the mean prednisolone dosage significantly decreased (6.1±7.6mg/day), compared to that in the baseline (11.3±9.5mg/day), and MGCS significantly improved after 12months of tacrolimus treatment, compared to that at the baseline. CONCLUSIONS: Our study showed that tacrolimus would be an effective immunosuppressant as an initial therapeutic agent in patients with MG; in addition, it showed tolerable safety profiles during the 12-month follow-up evaluation.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherElsevier-
dc.relation.isPartOfJOURNAL OF THE NEUROLOGICAL SCIENCES-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHDrug Therapy, Combination-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHImmunosuppressive Agents/adverse effects-
dc.subject.MESHImmunosuppressive Agents/therapeutic use-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHMyasthenia Gravis/drug therapy*-
dc.subject.MESHPrednisolone/therapeutic use-
dc.subject.MESHProspective Studies-
dc.subject.MESHTacrolimus/adverse effects*-
dc.subject.MESHTacrolimus/therapeutic use*-
dc.subject.MESHTime Factors-
dc.titleA multicenter prospective observational study on the safety and efficacy of tacrolimus in patients with myasthenia gravis-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Neurology-
dc.contributor.googleauthorSuk-Won Ahn-
dc.contributor.googleauthorIn Soo Joo-
dc.contributor.googleauthorByung-Jo Kim-
dc.contributor.googleauthorJung-Joon Sung-
dc.contributor.googleauthorSa-Yoon Kang-
dc.contributor.googleauthorJeeyoung Oh-
dc.contributor.googleauthorYang-Ki Minn-
dc.contributor.googleauthorBum Chun Suh-
dc.contributor.googleauthorSun-Young Oh-
dc.contributor.googleauthorYoon-Ho Hong-
dc.contributor.googleauthorTai-Seung Nam-
dc.contributor.googleauthorJung Im Seok-
dc.contributor.googleauthorYoung-Eun Park-
dc.contributor.googleauthorHa Young Shin-
dc.contributor.googleauthorEun Bin Cho-
dc.contributor.googleauthorJe-Young Shin-
dc.contributor.googleauthorHung Youl Seok-
dc.contributor.googleauthorJin-Sung Park-
dc.contributor.googleauthorJu-Hong Min-
dc.contributor.googleauthorJin-Myoung Seok-
dc.contributor.googleauthorByoung-Joon Kim-
dc.identifier.doi10.1016/j.jns.2017.05.060-
dc.contributor.localIdA02170-
dc.relation.journalcodeJ01897-
dc.identifier.eissn1878-5883-
dc.identifier.pmid28716258-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0022510X17303672-
dc.subject.keywordADR-
dc.subject.keywordMG-
dc.subject.keywordMGCS-
dc.subject.keywordMyasthenia gravis-
dc.subject.keywordPrednisolone-
dc.subject.keywordTacrolimus-
dc.contributor.alternativeNameShin, Ha Young-
dc.contributor.affiliatedAuthorShin, Ha Young-
dc.citation.volume379-
dc.citation.startPage271-
dc.citation.endPage275-
dc.identifier.bibliographicCitationJOURNAL OF THE NEUROLOGICAL SCIENCES, Vol.379 : 271-275, 2017-
dc.identifier.rimsid47645-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Neurology (신경과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.